386 related articles for article (PubMed ID: 18334298)
1. Targeting regions with highest lipid content on MR spectroscopy may improve diagnostic yield in stereotactic biopsy.
Ng WH; Lim T
J Clin Neurosci; 2008 May; 15(5):502-6. PubMed ID: 18334298
[TBL] [Abstract][Full Text] [Related]
2. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
[TBL] [Abstract][Full Text] [Related]
3. [Value of proton magnetic resonance spectroscopy with two-dimensional chemical-shift imaging in evaluating brain gliomas].
Zhou GF; Wang XY; Gong CG; Liu F; Wang RW
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Aug; 28(8):1342-4. PubMed ID: 18753055
[TBL] [Abstract][Full Text] [Related]
4. Recognition of anaplastic foci within low-grade gliomas using MR spectroscopy.
Bradac O; Vrana J; Jiru F; Kramar F; Netuka D; Hrabal P; Horinek D; de Lacy P; Benes V
Br J Neurosurg; 2014 Oct; 28(5):631-6. PubMed ID: 24377726
[TBL] [Abstract][Full Text] [Related]
5. Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weighted imaging.
Zeng QS; Li CF; Liu H; Zhen JH; Feng DC
Int J Radiat Oncol Biol Phys; 2007 May; 68(1):151-8. PubMed ID: 17289287
[TBL] [Abstract][Full Text] [Related]
6. In vitro study of astrocytic tumour metabolism by proton magnetic resonance spectroscopy.
Likavcanová K; Dobrota D; Liptaj T; Prónayová N; Mlynárik V; Belan V; Galanda M; Béres A; De Riggo J
Gen Physiol Biophys; 2005 Sep; 24(3):327-35. PubMed ID: 16308427
[TBL] [Abstract][Full Text] [Related]
7. Quantitative assessment of gliomas by proton magnetic resonance spectroscopy.
Oshiro S; Tsugu H; Komatsu F; Abe H; Onishi H; Ohmura T; Iwaasa M; Sakamoto S; Fukushima T
Anticancer Res; 2007; 27(6A):3757-63. PubMed ID: 17970039
[TBL] [Abstract][Full Text] [Related]
8. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
[TBL] [Abstract][Full Text] [Related]
9. In the assessment of supratentorial glioma grade: the combined role of multivoxel proton MR spectroscopy and diffusion tensor imaging.
Zou QG; Xu HB; Liu F; Guo W; Kong XC; Wu Y
Clin Radiol; 2011 Oct; 66(10):953-60. PubMed ID: 21663899
[TBL] [Abstract][Full Text] [Related]
10. Diagnostic value of proton magnetic resonance spectroscopy in the noninvasive grading of solid gliomas: comparison of maximum and mean choline values.
Senft C; Hattingen E; Pilatus U; Franz K; Schänzer A; Lanfermann H; Seifert V; Gasser T
Neurosurgery; 2009 Nov; 65(5):908-13; discussion 913. PubMed ID: 19834403
[TBL] [Abstract][Full Text] [Related]
11. Proton magnetic resonance spectroscopy of brain tumors correlated with pathology.
Magalhaes A; Godfrey W; Shen Y; Hu J; Smith W
Acad Radiol; 2005 Jan; 12(1):51-7. PubMed ID: 15691725
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive histologic grading of solid astrocytomas using proton magnetic resonance spectroscopy.
Fountas KN; Kapsalaki EZ; Vogel RL; Fezoulidis I; Robinson JS; Gotsis ED
Stereotact Funct Neurosurg; 2004; 82(2-3):90-7. PubMed ID: 15305081
[TBL] [Abstract][Full Text] [Related]
13. Cerebral gliomas: prospective comparison of multivoxel 2D chemical-shift imaging proton MR spectroscopy, echoplanar perfusion and diffusion-weighted MRI.
Yang D; Korogi Y; Sugahara T; Kitajima M; Shigematsu Y; Liang L; Ushio Y; Takahashi M
Neuroradiology; 2002 Aug; 44(8):656-66. PubMed ID: 12185543
[TBL] [Abstract][Full Text] [Related]
14. Magnetic resonance imaging and spectroscopy of pilomyxoid astrocytomas: case reports and comparison with pilocytic astrocytomas.
Morales H; Kwock L; Castillo M
J Comput Assist Tomogr; 2007; 31(5):682-7. PubMed ID: 17895777
[TBL] [Abstract][Full Text] [Related]
15. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
[TBL] [Abstract][Full Text] [Related]
16. Proton magnetic resonance spectroscopic imaging to differentiate between nonneoplastic lesions and brain tumors in children.
Hourani R; Horská A; Albayram S; Brant LJ; Melhem E; Cohen KJ; Burger PC; Weingart JD; Carson B; Wharam MD; Barker PB
J Magn Reson Imaging; 2006 Feb; 23(2):99-107. PubMed ID: 16374884
[TBL] [Abstract][Full Text] [Related]
17. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
[TBL] [Abstract][Full Text] [Related]
18. Stereotactic biopsy in gliomas guided by 3-tesla 1H-chemical-shift imaging of choline.
Hermann EJ; Hattingen E; Krauss JK; Marquardt G; Pilatus U; Franz K; Setzer M; Gasser T; Tews DS; Zanella FE; Seifert V; Lanfermann H
Stereotact Funct Neurosurg; 2008; 86(5):300-7. PubMed ID: 18791331
[TBL] [Abstract][Full Text] [Related]
19. [Changes in 1H-MRS in glioma patients before and after irradiation: the significance of quantitative analysis of choline-containing compounds].
Isobe T; Matsumura A; Anno I; Nagatomo Y; Yoshizawa T; Itai Y; Nose T
No Shinkei Geka; 2003 Feb; 31(2):167-72. PubMed ID: 12616652
[TBL] [Abstract][Full Text] [Related]
20. [Diagnosis of brain tumor with proton MR spectroscopy--the quantification of gliomas compared with normal brain].
Yu HW; Tanabe S; Yamaki T; Harada K; Hashi K
No Shinkei Geka; 2000 Dec; 28(12):1063-9. PubMed ID: 11193526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
